This condition is termed chronic granulomatous disease (CGD) and is traceable to genetic disruptions of NADPH oxidase, i.e. in approximately 65% of cases to mutations of the Cybb gene encoding the cytochrome b-245 H chain catalytic subunit [5]. Here, FMO5 is linked to chronic granulomatous disease.